These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 26484409)
41. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA. Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694 [TBL] [Abstract][Full Text] [Related]
42. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive. Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173 [TBL] [Abstract][Full Text] [Related]
43. Utility of Tumor Capsule Thickness as a Predictor of Invasion in Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and a Diagnostic Tool for Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features. French B; Hattier G; Mardekian SK Int J Surg Pathol; 2020 Feb; 28(1):13-19. PubMed ID: 31256687 [No Abstract] [Full Text] [Related]
44. Frequency of thyroid cancer in patients operated at Cantonal Hospital Zenica, Bosnia and Herzegovina, in the period 2007-2014. Hrnčić N; Goga A; Hrnčić S; Filipovska-Mušanović M; Hatibović H; Hodžić Ð Med Glas (Zenica); 2016 Aug; 13(2):113-7. PubMed ID: 27313111 [TBL] [Abstract][Full Text] [Related]
45. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161 [TBL] [Abstract][Full Text] [Related]
46. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy? Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408 [TBL] [Abstract][Full Text] [Related]
47. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants. Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022 [TBL] [Abstract][Full Text] [Related]
48. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364 [TBL] [Abstract][Full Text] [Related]
49. [Differentiated carcinoma of the thyroid gland in an area of endemic goiter. Clinical study and prognostic correlation]. Mato A; Gippini A; Peino R; Gayoso P; Uriel B An Med Interna; 1996 Nov; 13(11):537-40. PubMed ID: 9019212 [TBL] [Abstract][Full Text] [Related]
50. Long-term progression of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center retrospective study of the French Marne-Ardennes thyroid cancer registry. Richard C; Debreuve-Theresette A; Patey M; Brabencova E; Filieri C; Zalzali M; Schvartz C Ann Endocrinol (Paris); 2020 Feb; 81(1):34-38. PubMed ID: 32057425 [TBL] [Abstract][Full Text] [Related]
51. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Westbury C; Vini L; Fisher C; Harmer C Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555 [TBL] [Abstract][Full Text] [Related]
52. Encapsulated follicular variant of papillary thyroid carcinoma/noninvasive follicular thyroid neoplasm with papillary-like nuclear features with Spindle Cell Metaplasia: Case report and review of literature. Haroon Al Rasheed MR; Acosta A; Tarjan G Pathol Res Pract; 2017 Apr; 213(4):416-421. PubMed ID: 28216141 [TBL] [Abstract][Full Text] [Related]
53. IS MEASUREMENT OF CIRCULATING TUMOR DNA OF DIAGNOSTIC USE IN PATIENTS WITH THYROID NODULES? Lupo M; Guttler R; Geck Z; Tonozzi TR; Kammesheidt A; Braunstein GD Endocr Pract; 2018 May; 24(5):453-459. PubMed ID: 29498908 [TBL] [Abstract][Full Text] [Related]
54. Increased incidence of thyroid cancer in Navarra (Spain). Evolution and clinical characteristics, 1986-2010. Rojo Álvaro J; Bermejo Fraile B; Menéndez Torre E; Ardanaz E; Guevara M; Anda Apiñániz E Endocrinol Diabetes Nutr; 2017; 64(6):303-309. PubMed ID: 28604340 [TBL] [Abstract][Full Text] [Related]
55. Childhood thyroid cancer in England and Wales. Harach HR; Williams ED Br J Cancer; 1995 Sep; 72(3):777-83. PubMed ID: 7669594 [TBL] [Abstract][Full Text] [Related]
56. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes. Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950 [TBL] [Abstract][Full Text] [Related]